Patient Name : MRS.
KANTA Registered On : 15/08/2025 17:52
Patient ID : 2501007943 Collected On : 15/08/2025 17:52
Age / Gender : 72 YEAR(S) / FEMALE Reported On : 15/08/2025 19:41
Ref. By : DR SELF Report Status : FINAL
Client Name : OPD Sample Type :
COMPLETE BLOOD COUNT (CBC)
Parameter Name Value Unit Reference Range
Hemoglobin 11.5 g/dL 12.0 - 16.0
RBC Count 4.10 million/cmm 4.2 - 6.2
Hematrocrit 30.5 % 40 - 54
MCV 74.39 fL 80 - 96
MCH 28.05 Pg 27 - 33
MCHC 37.7 g/dL 32 - 36
RDW- CV 16.1 % 11 - 16
RDW-SD 39.9 fL 35 - 56
PLATELET COUNT 0.98 lacs/cumm 1.5 - 4.5
MPV 9.3 fL 6.5 - 12.0
PDW 15.6 25.0 - 65.0
TOTAL COUNT (WBC), EDTA blood 14.5 10³/µL 4.0-10.0
DIFFERENTIAL WBC COUNT (Manual By Microscopy)
Neutrophils (%) 90 % 38 - 70
Lymphocytes (%) 04 % 20 - 45
Monocytes (%) 4 % 2-8
Eosinophils (%) 2 % 1-6
Basophils (%) 0 % 0-1
Neutrophils (Abs) 13.05 10³/µL
Lymphocytes (Abs) 0.58 10³/µL
Monocytes (Abs) 0.58 10³/µL
Eosinophils (Abs) 0.29 10³/µL
Basophils (Abs) 00 10³/µL
Remark : Kindly correlate clinically. Advised for recheck from fresh sample in case, it is not correlated clinically, to rule out any pre-
analytic error (This device performs hematology analyses according to the hydrodynamic focusing (DC method) , Flow cytometry method
using a semiconductor laser and SLS - Hemoglobin method)
NOTE : - KINDLY CORRELATE WITH CLINICAL CONDITION
Scan To Validate
---------------------------------------------- END OF REPORT ----------------------------------------------
Page 1 of 10
Patient Name : MRS. KANTA Registered On : 15/08/2025 17:52
Patient ID : 2501007943 Collected On : 15/08/2025 17:52
Age / Gender : 72 YEAR(S) / FEMALE Reported On : 15/08/2025 19:41
Ref. By : DR SELF Report Status : FINAL
Client Name : OPD Sample Type :
ESR 1 HOUR
Parameter Name Value Unit Reference Range
ESR, EDTA whole blood 38 mm/hr 05-17 Yrs : <10,
17-50 Yrs : <12,
51-60 Yrs : <19,
61-70 Yrs : <20,
>70 Yrs: <30
Capillary microphotometer
NOTE : - KINDLY CORRELATE WITH CLINICAL CONDITION
Scan To Validate
---------------------------------------------- END OF REPORT ----------------------------------------------
Page 2 of 10
Patient Name : MRS. KANTA Registered On : 15/08/2025 17:52
Patient ID : 2501007943 Collected On : 15/08/2025 17:52
Age / Gender : 72 YEAR(S) / FEMALE Reported On : 15/08/2025 19:41
Ref. By : DR SELF Report Status : FINAL
Client Name : OPD Sample Type :
HEMOGLOBIN A1 C ESTIMATION (EDTA BLOOD)
Parameter Name Value Unit Reference Range
Hb A1C 8.1 % % of Total Hb>8.0 Action Suggested
<7.0 Goal
<6.0 Non-diabetic level
MATHOD -BIO-RAD HPLC
Mean Blood Glucose 185.77 mg/dL 0 - 154
Calculated
Degree of Glucose Control Normal Range:Poor Control >7.0% *Good Control 6.0 - 7.0 %**Non-diabetic level < 6.0 %* High risk of
developing long term complication such as retinopathy, nephropathy, neuropathy, cardiopathy,etc.* Some danger of hypoglycemic
reaction in Type I diabetics.* Some glucose intolerant individuals and "subclinical" diabetics may demonstrate HbA1c levels in this
area. HbA1c is used for monitoring diabetic control. It reflects the estimated average glucose (eAG).- Trends in HbA1c are a better
indicator of diabetic control than a solitary test.- To estimate the eAG from the HbA1C value, the following equation is used: eAG(mg/dl) =
28.7*A1c-46.7- HbA1C Estimation can get affected due to .1) Anaemia .2) Chronic renal failure .3) Vitamin A .4) Vitamin C .5) HbA1c is
falsely low in diabetics with hemolytic disease Fructosamine is recommended in these patients whichindicates diabetes control over 15
days .6) Interference of Haemoglobinopathies in HbA1c estimation .A) HbF > 5%, an alternate platform (Boronate affinity
chromatography) is recommended for testing of HbA1c.B) Homozygous hemoglobinopathy is detected, fructosamine is recommended for
monitoring diabetic statusC) Heterozygous state detected (D10/ turbo is corrected for HbS and HbC trait).Hemoglobin electrophoresis
(HPLC method) is recommended for detecting hemoglobinopathy.
NOTE : - KINDLY CORRELATE WITH CLINICAL CONDITION
Scan To Validate
---------------------------------------------- END OF REPORT ----------------------------------------------
Page 3 of 10
Patient Name : MRS. KANTA Registered On : 15/08/2025 17:52
Patient ID : 2501007943 Collected On : 15/08/2025 17:52
Age / Gender : 72 YEAR(S) / FEMALE Reported On : 15/08/2025 19:41
Ref. By : DR SELF Report Status : FINAL
Client Name : OPD Sample Type :
LIPID PROFILE
Fully Automated Analyzer
Parameter Name Value Unit Reference Range
Total Cholesterol 121.3 mg/dL Desirable <200
Borderline high 200 - 240
high >240
Fully Automatic Analyser
Triglyceride 255.8 mg/dL Desirable <161
High 161-199
Hypertriglyceridemic 200-
499
Very high 200-499
Fully Automatic Analyser
HDL Cholesterol Direct 42.70 mg/dL < 40.0 LOW
> 60.0 HIGH
Fully Automatic Analyser
Direct LDL 37.67 mg/dL Desirable : < 130.0
Borderline High : 130-159
High : 160-189
Very High : >190.0
Cholesterol /HDL Ratio 2.84 mg/dL 0 - 5.0
Calculated
LDL / HDL RATIO 0.88 mg/dL 0 - 3.5
Calculated
VLDL 51.16 mg/dL Desirable < 40
Borderline high 40-80
High 80-200
very high >200
Calculated
Interpretation : "Lipid" is simply a medical term for "fat". A lipid profile measures fatty substances in your blood. Cholesterol is one
type of fat. When you eat food containing cholesterol or when your body produces cholesterol and releases it into your bloodstream, the
cholesterol will attach to a protein. This package of cholesterol plus a protein is called a lipoprotein (lipid or fat plus protein). A lipid
profile measures lipoprotein levels in your blood.(Disclaimer: Information provided here in the remarks section is purely for patient
education and should not be used as a substitute for advice of an appropriately qualified and licensed physician or other healthcare
provider. We do not take responsibility for any damages with respect to accuracy or use of the information.)
NOTE : - KINDLY CORRELATE WITH CLINICAL CONDITION
Scan To Validate
---------------------------------------------- END OF REPORT ----------------------------------------------
Page 4 of 10
Patient Name : MRS. KANTA Registered On : 15/08/2025 17:52
Patient ID : 2501007943 Collected On : 15/08/2025 17:52
Age / Gender : 72 YEAR(S) / FEMALE Reported On : 15/08/2025 19:41
Ref. By : DR SELF Report Status : FINAL
Client Name : OPD Sample Type :
LIVER FUNCTION TEST
Fully Automated Analyzer
Parameter Name Value Unit Reference Range
Total Bilirubin 1.39 mg/dL 0.20 - 1.20
Fully Automatic Anlyzer
Direct Bilirubin 0.81 mg/dL 0.10 - 0.60
Fully Automatic Anlyzer
Indirect Bilirubin 0.58 mg/dL 0.0 - 1.1
Calculated
SGOT AST (Serum glutamic oxaloacetic ) 65.34 U/L 0 - 40
Fully Automatic Anlyzer
SGPT ALT ( Serum Glutamic Pyruvic ) 73.90 U/L 05-40
Fully Automated Analyzer
Alakaline Phosphatase 130.3 U/L 46 - 117
Fully Automatic Analyser
Total Protein 4.83 g/dL 6.4 - 8.2
Fully Automatic Analyser
Albumin 2.50 g/dL 3.4 - 5.0
Fully Automatic Analyser
Globulin 2.33 g/dL 2.7 - 3.5
Calculated
A/G Ratio 1.07 0.8 - 2.0
Calculated
Remark : Kindlly correlate clinically. Advised for recheck from fresh sample in case, if it is not correlated clinically, to rule out any pre-
analytic error
Interpretation : Your liver is a vital organ in your body, and it performs multiple functions. The health and
effectiveness of your liver can be determined with liver function tests(LFT's) that measure several benchmarks of liver activities.
NOTE : - KINDLY CORRELATE WITH CLINICAL CONDITION
Scan To Validate
---------------------------------------------- END OF REPORT ----------------------------------------------
Page 5 of 10
Patient Name : MRS. KANTA Registered On : 15/08/2025 17:52
Patient ID : 2501007943 Collected On : 15/08/2025 17:52
Age / Gender : 72 YEAR(S) / FEMALE Reported On : 15/08/2025 19:41
Ref. By : DR SELF Report Status : FINAL
Client Name : OPD Sample Type :
KIDNEY PANEL
Fully Automated Analyzer
Parameter Name Value Unit Reference Range
UREA 88.72 mg/dL 15 - 40
Fully Automatic Analyser
BUN 41.43 mg/dL 11.0 - 23.0
Calculated
Creatinine 1.95 mg/dL 0.55 - 1.40
Fully Automatic Analyser
.
Uric Acid 4.87 mg/dL 2.6 - 7.2
Fully Automatic Analyser
Sodium 130.0 mmol/L 135 - 155
ION SELECTIVE ELECTRODE
Potassium 4.02 mmol/L 3.5 - 5.5
ION SELECTIVE ELECTRODE
Chloride 90.0 mmol/L 94 - 110
ION SELECTIVE ELECTRODE
BUN/CREATININE RATIO 21.25
Calculated
UREA CREATININE RATIO 45.5 %
Calculated
ESTIMATED GFR 30.56 60 - 115 mL/min/1.73 m²
Calculated
The National Kidney Foundation recommends using the Estimated GFR using MDRD Creatinine Equation (2021) to estimate GFR.
(http://surl.li/lwaub) Kindly correlate clinically. Advise for recheck from fresh sample in case, it is not correlation clinically, to rule out any
preanalytical error.
NOTE : - KINDLY CORRELATE WITH CLINICAL CONDITION
Scan To Validate
---------------------------------------------- END OF REPORT ----------------------------------------------
Page 6 of 10
Patient Name : MRS. KANTA Registered On : 15/08/2025 17:52
Patient ID : 2501007943 Collected On : 15/08/2025 17:52
Age / Gender : 72 YEAR(S) / FEMALE Reported On : 15/08/2025 19:41
Ref. By : DR SELF Report Status : FINAL
Client Name : OPD Sample Type :
THYROID FUNCTION TEST
SPECIMEN: SERUM
Parameter Name Value Unit Reference Range
T3 (Triiodothyronine) 0.52 ng/mL upto 2 years 1.17 to 2.39
2 - 12 years 1.05 to 2.07
13- 21 years 0.86 to 1.92
>21 years 0.6 to 1.80
Trimester
1st 0.81 – 1.90
2nd 1.00 – 2.60
3rd 1.00 – 2.60
Method : By Chemiluminescence.
T4 (Thyroxine) 3.49 mcg/dl upto 2 years 6.00 to 19.9
2 - 12 years 5.50 to 15.10
13- 21 years 5.50 to 14.10
>21 years 4.5 to 14.10
Method : By Chemiluminescence.
TSH 3.81 µIU/ml 0.35 to 5.55
During Pregnancy
(Trimester)
First: 0.26 - 2.66
Second: 0.55 - 2.73
Third: 0.43 - 2.91
0.5 - 10.6 (UP TO 1 YEARS)
Method : By Chemiluminescence.
Interpretation :
TSH levels may be affected by acute illness and drugs like doapamine and gluco corticoids.Low or undetectable TSH is suggestive of
Grave~s disease.TSH between 5.5 to 15.0 with normal T3 T4 indicates impaired thyroid hormone or subclinical hypothyroidism or normal
T3 T4 wi this lightly low TSH suggests subclinical Hyperthyroidism.TSH suppression does not reflect severity of hyperthyroidism therefore ,
measurement of FT3 ,FT4 is important.FreeT3 is first hormone to increase in early Hyperthyroidism. Only TSH level can prove to be
misleading in patients on treatment. Therefore FreeT3 , FreeT4 along with TSH should be checked.During pregnancy clinically T3 T4 can
be high and TSH can be slightly low.
NOTE : - KINDLY CORRELATE WITH CLINICAL CONDITION
Scan To Validate
---------------------------------------------- END OF REPORT ----------------------------------------------
Page 7 of 10
Patient Name : MRS. KANTA Registered On : 15/08/2025 17:52
Patient ID : 2501007943 Collected On : 15/08/2025 17:52
Age / Gender : 72 YEAR(S) / FEMALE Reported On : 15/08/2025 19:41
Ref. By : DR SELF Report Status : FINAL
Client Name : OPD Sample Type :
B12-VITAMIN B12
Parameter Name Value Unit Reference Range
VITAMIN B12 1684.7 pg/mL 211 - 911
CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY
Interpretation : Vitamin B-12, also called cobalamin, is a water-soluble vitamin with a key role in the normal functioning of the brain and
nervous system, and for the formation of blood. It is normally involved in the metabolism of every cell of the human body, especially
affecting DNA synthesis and regulation, but also fatty acid metabolism and amino acid metabolism. Vitamin B12 deficiency is most
commonly caused by low intakes, but can also result from mal-absorption, certain intestinal disorders, low presence of binding proteins,
and using of certain medications. Vitamin B12 is rare from plant sources, so vegetarians will be the vulnerable populations most likely to
suffer from vitamin B12 deficiency. Infants are at a higher risk of vitamin B12 deficiency if they were born to vegetarian mothers. The
elderly who have diets with limited meat or animal products are vulnerable populations as well. Vitamin B12 deficiency can manifest itself
as anemia and in some cases cause permanent neurological damage. At levels only slightly lower than normal, a range of symptoms
such as fatigue, depression, and poor memory may be experienced
NOTE : - KINDLY CORRELATE WITH CLINICAL CONDITION
Scan To Validate
---------------------------------------------- END OF REPORT ----------------------------------------------
Page 8 of 10
Patient Name : MRS. KANTA Registered On : 15/08/2025 17:52
Patient ID : 2501007943 Collected On : 15/08/2025 17:52
Age / Gender : 72 YEAR(S) / FEMALE Reported On : 15/08/2025 19:41
Ref. By : DR SELF Report Status : FINAL
Client Name : OPD Sample Type :
HYDROXY VITAMIN D LEVELS
Method : eCLIA
Parameter Name Value Unit Reference Range
1.25 - DIHYDROXY VIT D3 5.01 pg/mL 15 - 65
Interpretation :
Vitamin D promotes absorption of calcium and phosphorus and mineralization of bones and teeth .
Deficiency in children causes Rickets and in adults leads to Osteomalacia.
It can also lead to Hypocalcemia and Tetany.
Vitamin D status is best determined by measurement of 25 hydroxy vitamin D, as it is the major circulating form and has longer half life (2
-3 weeks) than 1,25 Dihydroxy vitamin D (5-8 hrs).
Decreased Levels:
· Inadequate exposure to sunlight
· Dietary deficiency
· Vitamin D malabsorption
· Severe Hepatocellular disease
· Drugs like Anticonvulsants
· Nephrotic syndrome
Increased levels:
Vitamin D intoxication
NOTE : - KINDLY CORRELATE WITH CLINICAL CONDITION
Scan To Validate
---------------------------------------------- END OF REPORT ----------------------------------------------
Page 9 of 10
Patient Name : MRS. KANTA Registered On : 15/08/2025 17:52
Patient ID : 2501007943 Collected On : 15/08/2025 17:52
Age / Gender : 72 YEAR(S) / FEMALE Reported On : 15/08/2025 19:41
Ref. By : DR SELF Report Status : FINAL
Client Name : OPD Sample Type :
RANDOM PLASMA GLUCOSE
Specimen: Flouride plasma
Parameter Name Value Unit Reference Range
Random Blood Sugar (RBS) 236.2 mg/dL 70 - 140
Note
1. The diagnosis of Diabetes requires a fasting plasma glucose of > or = 126 mg/dL and/or a random / 2
hr post glucose value of > or = 200 mg/dL on at least 2 occasions
2. Very low glucose levels cause severe CNS dysfunction
3. Very high glucose levels (>450 mg/dL in adults) may result in Diabetic Ketoacidosis & is considered
critical
NOTE : - KINDLY CORRELATE WITH CLINICAL CONDITION
Scan To Validate
---------------------------------------------- END OF REPORT ----------------------------------------------
Page 10 of 10
